Generalized Anxiety Disorder
Conditions
Keywords
GAD, VR
Brief summary
The goal of this clinical trial is to apply Virtual Reality as an adjunct treatment for Generalized Anxiety Disorder. The main question it aims to answer are: * Determination of the efficacy of VR modules as an adjunct therapy in improving GAD-7 scores * Assessment of the acceptability of VR modules as an adjunct therapy to the standard of care Participants will randomized into two arms: * Control Arm: Standard of Care only * Intervention Arm: Standard of Care + VR Modules
Interventions
OTHERVirtual Reality
Virtual Reality as adjunct treatment
Sponsors
Clinical Research Centre, Malaysia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
No
Inclusion criteria
1. Age between 18-59 2. The primary diagnosis is a generalized anxiety disorder 3. Agree to participate and consented as per study protocol. 4. There is no change in the standard of care within the past two months prior to enrollment into the study. If a patient is on any psychotherapy, then there is no change in the type of current psychotherapy intervention. 5. GAD- 7 more than or equal to 5. 6. Able to come for the session as per scheduled.
Exclusion criteria
1. Documented or known case of permanent hearing/visual impairment e.g., vestibular abnormalities that represent significant contraindications for the use of VR or visual impairment e.g., cataract. 2. Documented Disorder as listed: * A. Psychosis * B. Psychosis disorder - previous case, known case of * C. Claustrophobia * D. Substance use * E. Personality disorder * F. Visual impairment that might hinder usage of virtual reality equipment * G. Intellectual disabilities * H. All types of seizures including febrile seizure 3. The patient is under more than 1 center during follow up (e.g., patient is also receiving treatment from a private hospital for GAD).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To determine the efficacy of VR modules as an adjunct therapy in improving GAD-7 scores among patients with generalized anxiety disorders. | Week 0 - Week 4 | Patient will be access with GAD-7 questionnaire repeatedly at different time interval (3 Times - Week 0, Week 2, Week 4) . |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To assess the acceptability of VR modules as an adjunct therapy to the standard of care among patients with generalized anxiety disorders. | Week 0 - Week 4 | Patient will assess with standard questionnaire on acceptability of VR technology (3 Times - Week 0, Week 2, Week 4). |
Countries
Malaysia
Outcome results
None listed